The effect of dendrimers on the pharmacodynamic and pharmacokinetic behaviors of non-covalently or covalently attached drugs
- 1 November 2008
- journal article
- review article
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 43 (11) , 2291-2297
Abstract
No abstract availableKeywords
This publication has 59 references indexed in Scilit:
- Folate coupled poly(ethyleneglycol) conjugates of anionic poly(amidoamine) dendrimer for inflammatory tissue specific drug deliveryJournal of Biomedical Materials Research Part A, 2007
- Dendrimers as drug delivery vehicles: non‐covalent interactions of bioactive compounds with dendrimersPolymer International, 2007
- Designing a molecular delivery system within a preclinical timeframeDrug Discovery Today, 2007
- The development of folate-PAMAM dendrimer conjugates for targeted delivery of anti-arthritic drugs and their pharmacokinetics and biodistribution in arthritic ratsBiomaterials, 2007
- A single dose of doxorubicin-functionalized bow-tie dendrimer cures mice bearing C-26 colon carcinomasProceedings of the National Academy of Sciences, 2006
- Characterization of dendrimersAdvanced Drug Delivery Reviews, 2005
- Targeted drug delivery with dendrimers: Comparison of the release kinetics of covalently conjugated drug and non-covalent drug inclusion complexAdvanced Drug Delivery Reviews, 2005
- Synthesis, characterization, activities, cell uptake and DNA binding of trinuclear complex: [{trans-PtCl(NH3)}2μ-{trans-Pt(NH3)(2-hydroxypyridine)-(H2N(CH2)6NH2)2]Cl4European Journal of Medicinal Chemistry, 2005
- Targeting Cancer Cells with DendrimersChemistry & Biology, 2005
- The effect of PAMAM dendrimer generation size and surface functional group on the aqueous solubility of nifedipineInternational Journal of Pharmaceutics, 2004